Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for OCTREOTIDE FOR INJECTABLE SUSPENSION

Brand name

OCTREOTIDE FOR INJECTABLE SUSPENSION

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02503786

Ingredients & Strength

OCTREOTIDE (30 MG)

ATC Code

H01CB

ATC Descriptor

HYPOTHALAMIC HORMONES

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
OCTREOTIDE FOR INJECTABLE SUSPENSION	1	Resolved	2022-08-18	2024-06-13	166975
OCTREOTIDE FOR INJECTABLE SUSPENSION	2ml	Resolved	2024-10-11	2024-11-08	240046
OCTREOTIDE FOR INJECTABLE SUSPENSION	Vial Kit	Resolved	2024-11-28	2025-05-30	244081
OCTREOTIDE FOR INJECTABLE SUSPENSION	8mL	Resolved	2025-07-29	2025-08-29	263746
OCTREOTIDE FOR INJECTABLE SUSPENSION	ALL	Actual shortage	2025-12-18	2025-12-18	274595

1

Showing 1 to 5 of 5

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0